Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Compass Pathways | 312 | 2023q3 | |||||||||
Compugen | 164 | 2021 | |||||||||
CONMED | 2,330 | 2023 | |||||||||
Cooper Companies | 19,999 | 2024q3 | |||||||||
Corbus Pharmaceuticals Ho... | 85 | 2023q3 | |||||||||
Corcept Therapeutics | 2,432 | 2021 | |||||||||
CRISPR Therapeutics | 3,868 | 2023q3 | |||||||||
Cronos Group | 779 | 2023q3 | |||||||||
CSPC Pharmaceutical | 8,910 | 2023 | |||||||||
Cutera | 321 | 2023q2 | |||||||||
CV Sciences | 4 | 2021 | |||||||||
Daiichi Sankyo Company | 56,436 | 2023q1 | |||||||||
Danaher | 176,048 | 2021 | |||||||||
DaVita | 7,312 | 2023q3 | |||||||||
Denali Therapeutics | 3,340 | 2024q2 | |||||||||
Dentsply Sirona | 6,046 | 2023q3 | |||||||||
DexCom | 26,258 | 2023q3 | |||||||||
Doximity | 10,867 | 2024q3 | |||||||||
Dr. Reddy's Laboratories | 2,515 | 2024q1 | |||||||||
Eagle Pharmaceuticals | 60 | 2023q2 |